Increase in bilateral trade & investment, co-operation on global security matters, inclusion of India in decision-making on matters of global governance (United Nations Security Council), upgraded representation in trade & investment forums (World Bank, IMF, APEC), admission into multilateral export control regimes (MTCR, Wassenaar Arrangement, Australia Group) and support for admission in the Nuclear Suppliers Group and joint-manufacturing through technology sharing arrangements have become key milestones and a measure of speed and advancement on the path to closer US–India relations. In 2016, India and the United States signed the Logistics Exchange Memorandum of Agreement and India was declared a Major Defense Partner of the United States. In 2020, India had provided its agreement for terminating an export embargo on a medicinal drug known as hydroxychloroquine that US President Donald Trump had labelled as being a "game-changer", amidst the combat against the ongoing global coronavirus (COVID-19) disease pandemic. The judgement emerged after Trump threatened retaliation against India, if it did not comply with terminating the export embargo on hydroxychloroquine.